<DOC>
	<DOCNO>NCT01265459</DOCNO>
	<brief_summary>The purpose study assess safety efficacy profile new single-injection volume Durolane patient knee OA .</brief_summary>
	<brief_title>Different Volumes Durolane Knee OA</brief_title>
	<detailed_description>To assess safety efficacy profile different volume Durolane patient knee OA compare current standard single-injection product . The study aim investigate whether different volume Durolane compare standard injection volume improve benefit/risk profile .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Subject ( female male ) 4085 year age Unilateral knee pain fulfilling American College Rheumatology ( ACR ) criteria diagnosis osteoarthritis ( OA ) Radiographic evidence OA study knee WOMAC pain score 717 study knee WOMAC pain score 23 study knee ( WOMAC Likert 3.1 A1 ) Subject normally active Subject attempt respond adequately previous nonpharmacological therapy ( y ) simple analgetics Subject cooperative able communicate effectively investigator Body mass index â‰¤ 35 kg/m2 ; Signed informed consent obtain Knee effusion Contralateral knee OA Clinically significant joint pain joint knee Previous intraarticular steroid injection study knee within last 6 month Previous intraarticular Hyaluronic Acid ( HA ) injection study knee within last 9 month Previous allergic type reaction HA product Treatment analgesic paracetamol ( acetaminophen ) ( include topical agent knee ) within 5 half life drug prior baseline visit Use analgesics 48 hour precede baseline visit Use systemic glucocorticosteroids ( exclude inhale steroid ) within last 3 month Treatment glucosamine/chondroitin sulfate initiate within past 3 month Change physical therapy knee within last three month Arthroscopy surgical procedure study knee within past 12 month Serious injury study knee past Any plan arthroscopy surgical procedure study period Previous history presence active septic arthritis Active skin disease infection area injection site Systemic active inflammatory condition infection Bleeding diathesis use anticoagulant History drug alcohol abuse within 6 month Any medical condition opinion investigator make subject unsuitable inclusion Pregnant breastfeed woman woman childbearing potential practicing adequate contraception Involvement clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>